| Literature DB >> 20943818 |
Lisa Lindqvist1, Francis Robert, William Merrick, Hideaki Kakeya, Christopher Fraser, Hiroyuki Osada, Jerry Pelletier.
Abstract
The ansamycins are a diverse and often physiologically active group of compounds that include geldanamycin and rifamycin, inhibitors of heat shock protein 90 and prokaryotic DNA-dependent RNA synthesis, respectively. Cytotrienin A is an ansamycin-type small molecule with potent antiproliferative and proapoptotic properties. Here, we report that this compound inhibits eukaryotic protein synthesis by targeting translation elongation and interfering with eukaryotic elongation factor 1A function. We also find that cytotrienin A prevents HUVEC tube formation and diminishes microvessel formation in the chorioallantoic membrane assay. These results provide a molecular understanding into cytotrienin A's previously reported properties as an anticancer apoptosis-inducing drug.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20943818 PMCID: PMC2995401 DOI: 10.1261/rna.2307710
Source DB: PubMed Journal: RNA ISSN: 1355-8382 Impact factor: 4.942